• 1
    Schrier RW, Wang W, Poole B, Mitra A. Acute renal failure: Definitions, diagnosis, pathogenesis, and therapy. J Clin Invest 2004; 114: 514.
  • 2
    Lamiere N, Van Biesen W, Vanholder R. Acute renal failure. Lancet 2005; 365: 417430.
  • 3
    Devarajan P. Cellular and molecular derangements in acute tubular necrosis. Curr Opin Pediatr 2005; 17: 193199.
  • 4
    Hewitt SM, Dear J, Star RA. Discovery of protein biomarkers for renal diseases. J Am Soc Nephrol 2004; 15: 16771689.
  • 5
    Bellomo R, Kellum JA, Ronco C. Defining acute renal failure: Physiological principles. Intensive Care Med 2004; 30: 3337.
  • 6
    Perico N, Cattaneo D, Sayegh MH, Remuzzi G. Delayed graft function in kidney transplantation. Lancet 2004; 364: 18141827.
  • 7
    Ojo AO, Wolfe RA, Held PJ, Port FK, Schmouder RL. Delayed graft function: Risk factors and implications for renal allograft survival. Transplantation 1997; 63: 968974.
  • 8
    Koning OH, Ploeg RJ, Van Bockel H et al. Risk factors for delayed graft function in cadaveric kidney transplantation: A prospective study of renal function and graft survival after preservation with University of Wisconsin solution in multi-organ donors. Transplantation 1997; 63: 16201628.
  • 9
    Jacobs SC, Cho E, Foster C, Liao P, Bartlett ST. Laparoscopic donor nephrectomy: The University of Maryland 6-year experience. J Urol 2004; 171: 4751.
  • 10
    Lu CY, Penfield JG, Kielar ML, Vasquez MA, Jeyarajah DR. Hypothesis: Is renal allograft rejection initiated by the response to injury sustained during the transplant process? Kidney Int 1999; 55: 21572168.
  • 11
    Sayegh MH. Why do we reject a graft? Role of indirect allorecognition in graft rejection. Kidney Int 1999; 65: 19671979.
  • 12
    Boom H, Mallat MJ, De Fijter JW, Zwinderman AH, Paul LC. Delayed graft function influences renal function, but not survival. Kidney Int 2000; 58: 859866.
  • 13
    Giral-Classe M, Hourmant M, Cantarovich D et al. Delayed graft function of more than six days strongly decreases long-term survival of transplanted kidneys. Kidney Int 1998; 54: 972978.
  • 14
    Shoskes DA, Cecka M. Deleterious effects of delayed graft function in cadaveric renal transplant recipients independent of acute rejection. Transplantation 1998; 66: 16971701.
  • 15
    Troppman C, Gruessner AC, Gillingham KJ, Sutherland DE, Matas AJ, Gruessner RW. Impact of delayed graft function on long-term graft survival after solid organ transplantation. Transplant Proc 1999; 31: 12901292.
  • 16
    Woo YM, Jardine AG, Clark AF et al. Early graft function and patient survival following cadaveric renal transplantation. Kidney Int 1999; 55: 692699.
  • 17
    Tejani AH, Sullivan EK, Alexander SR, Fine RN, Harmon WE, Kohaut EC. Predictive factors for delayed graft function (DGF) and its impact on renal graft survival in children: a report of the North American Pediatric Renal Transplant Cooperative Study (NAPRTCS). Pediatr Transplant 1999; 3: 293300.
  • 18
    Prommool S, Jhangri GS, Cockfield SM, Halloran PF. Time dependency of factors affecting renal allograft survival. J Am Soc Nephrol 2000; 11: 565573.
  • 19
    Halloran PF, Hunsicker LG. Delayed graft function: state of the art, Nov 10–11, 2000. Summit Meeting, Scottsdale, Arizona, USA. Am J Transplant 2001; 1: 115120.
  • 20
    Salahudeen AK, Haider N, May W. Cold ischemia and the reduced long-term survival of cadaveric renal allografts. Kidney Int 2004; 65: 713718.
  • 21
    Irish WD, McCollum DA, Tesi RJ et al. Nomogram for predicting the likelihood of delayed graft function in adult cadaveric renal transplant recipients. J Am Soc Nephrol 2003; 14: 29672974.
  • 22
    Brier ME, Ray PC, Klein JB. Prediction of delayed renal allograft function using an artificial neural network. Nephrol Dial Transplant 2003; 18: 26552659.
  • 23
    Supavekin S, Zhang W, Kucherlapati R, Kaskel FJ, Moore LC, Devarajan P. Differential gene expression following early renal ischemia-reperfusion. Kidney Int 2003; 63: 17141724.
  • 24
    Mishra J, Ma Q, Prada A et al. Identification of NGAL as a novel urinary biomarker for ischemic injury. J Am Soc Nephrol 2003; 4: 25342543.
  • 25
    Devarajan P, Mishra J, Supavekin S, Patterson LT, Potter SS. Gene expression in early ischemic renal injury: Clues towards pathogenesis, biomarker discovery and novel therapeutics. Mol Genet Metab 2003; 80: 365376.
  • 26
    Mishra J, Dent C, Tarabishi R et al. Neutrophil gelatinase-associated lipocalin (NGAL) as a biomarker for acute renal injury following cardiac surgery. Lancet 2005; 365: 12311238.
  • 27
    Parikh CR, Jani A, Meinikov VY, Faubel S, Edelstein CL. Urinary Interleukin-18 is a marker of human acute tubular necrosis. Am J Kidney Dis 2004; 43: 405414.
  • 28
    Rodrigo E, Ruiz JC, Pinera C et al. Creatinine reduction ratio on post-transplant day two as criterion in defining delayed graft function. Am J Transplant 2004; 4: 11631169.
  • 29
    Kwon O, Molitoris BA, Pescovitz M, Kelly KJ. Urinary actin, interleukin-6, and interleukin-8 may predict sustained ARF after ischemic injury in renal allografts. Am J Kidney Dis 2003; 41: 10741087.
  • 30
    Mishra J, Mori K, Ma Q et al. Amelioration of ischemic acute renal injury by NGAL. J Am Soc Nephrol 2004; 15: 30733082.